Shelter Pharma Limited (BSE: 543963) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹75 Cr, it ranks #3,406 by market cap among the 6,197 Indian listed companies on FinBizNet, and #47 of 63 in Pharmaceuticals. At ₹45.00 (as of 10 Nov 2026), the share price is 19.5% below its 52-week high of ₹55.88 and 95.7% above its 52-week low of ₹23.00. The share price is up 7.8% over one year and up 73.1% over three months.
| Current Price | ₹45.00 |
|---|---|
| Market Cap | ₹75 Cr |
| BSE Code | 543963 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 8.6 |
| Return on Assets | 11.63% |
| 52-Week Range | ₹23.00 – ₹55.88 |
| 1-Year Price Change | +7.8% |
| 3-Month Price Change | +73.1% |
| Beta (1Y) | 0.31 |
| Dividend Yield | 0.00% |
| Headquarters | Ahmedabad, Gujarat |
| Website | shelter.co.in |
Delivery averaged 100.0% of traded volume across 15 BSE sessions (15 Oct 2026 – 6 Nov 2026).
Shelter Pharma Limited manufactures and sells pharmaceutical products for human and animals in India. The company offers tablets, ointments, syrups, capsules, and oil for human health care; and mineral mixture for veterinary health care. It also provides OTC and ethical products. The company sells its products through distribution network, as well as exports its products. Shelter Pharma Limited was founded in 1965 and is based in Ahmedabad, India.
1. Manufacturing of pharmaceuticals-This segment manufactures and sells herbal products for human and veterinary use. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacturing of pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹54,788 Cr | 35.3 | 34.46% | ₹1,814 Cr | -8.2% |
| Ajanta Pharma Limited | ₹42,432 Cr | 40.2 | 25.39% | ₹1,794 Cr | +35.7% |
| Emcure Pharmaceuticals Ltd | ₹35,726 Cr | 38.6 | 19.57% | ₹2,820 Cr | +67.0% |
| Piramal Pharma Ltd | ₹31,892 Cr | n/m | -4.00% | ₹2,617 Cr | +21.7% |
| RUBICON RESEARCH LIMITED | ₹27,601 Cr | 108.9 | 19.14% | ₹576 Cr | +186.9% |
| Caplin Point Laboratories Ltdte | ₹17,770 Cr | 27.8 | 19.94% | ₹610 Cr | +25.0% |
| Pfizer Ltd. | ₹16,646 Cr | 23 | 17.16% | ₹727 Cr | -24.3% |
| Eris Lifesciences Ltd | ₹16,096 Cr | 25.6 | 18.07% | ₹892 Cr | -21.1% |
| Shelter Pharma Limited | ₹75 Cr | 8.6 | — | — | +7.8% |
Listed by market capitalisation. Ratios are shown for context only.
Shelter Pharma Limited is trading at ₹45.00, with a market capitalisation of ₹75 Cr.
Shelter Pharma Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Shelter Pharma Limited has a P/E of 8.6.
Shelter Pharma Limited is listed on the BSE under the scrip code 543963.
Shelter Pharma Limited's share price is up 7.8% over one year and up 73.1% over three months. Its 52-week range is ₹23.00 to ₹55.88.
Data as of 10 Nov 2026. Descriptive market data only — not investment advice.